Everyone who has obesity or overweight that impacts their health and who wants treatment deserves access to it, Dr
Newborns are particularly at risk: If the mother has an active herpes infection, the child can easily become infected during birth
The dose-dependent nature of semaglutide-associated nodules, documented in the first published case report, suggests that dose reduction may resolve the problem when nodules occur repeatedly
Very important and practically oriented paper Nice overview of advantages and limitations A must read for anybody who treats these patients To view or add a comment, sign in GLP-1RAs Show Significant Liver and Metabolic Benefits in MASLD A new systematic review and meta-analysis of 32 randomized controlled trials reveals that GLP-1 receptor agonists (GLP-1RAs) significantly improve liver and metabolic outcomes in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), far outperforming DPP-4 inhibitors, which showed minimal effects beyond glycemic control
Phase 2: Sustained Weight Reduction (6-12 Months) As GLP-1 therapy progresses, weight loss accelerates, often peaking within the first 6-12 months
[45] Yang CS, Wang H